Guardian Angel Home Health Inc | |
717 S. Victory Blvd., Ste A, Burbank, California 91502 | |
(818) 559-2300 | |
Name | Guardian Angel Home Health Inc |
---|---|
Location | 717 S. Victory Blvd., Ste A, Burbank, California |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 59529 |
Ownership Type | Proprietary |
Service Area Zip Codes | 90025, 90027, 90028, 90029, 90032, 90035, 90038, 90039, 90046, 90403, 90404, 91040, 91042, 91104, 91201, 91202, 91203, 91205, 91206, 91207, 91208, 91302, 91303, 91304, 91306, 91307, 91316, 91325, 91335, 91344, 91356, 91360, 91364, 91367, 91403, 91405, 91406, 91411, 91423, 91502, 91504, 91505, 91506, 91601, 91605, 91606, 91607 |
NPI Number | 1871879361 |
Organization Name | GUARDIAN ANGEL HOME HEALTH, INC. |
Address | 717 S Victory Blvd Suite A, Burbank, CA 91502 |
Phone Number | 818-559-2300 |
News Archive
Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.
Senate leaders announced a deal late Tuesday to stave off deep cuts to physicians' Medicare payments by repurposing money set aside for the health law, Politico reports. The deal, announced by Senate Majority Leader Harry Reid, D-Nev., and Minority Leader Mitch McConnell, R-Ky., changes ... "how much money consumers would have to repay if they receive too large a subsidy in the health insurance exchanges after 2014.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
An inexpensive test and single-dose treatment could help save the lives of nearly one million infants annually if pregnant women in low-income countries were offered rapid tests for syphilis, experts from the Global Congenital Syphilis Partnership said on Thursday, Reuters reports.
› Verified 7 days ago
Quality Rating: |
News Archive
Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.
Senate leaders announced a deal late Tuesday to stave off deep cuts to physicians' Medicare payments by repurposing money set aside for the health law, Politico reports. The deal, announced by Senate Majority Leader Harry Reid, D-Nev., and Minority Leader Mitch McConnell, R-Ky., changes ... "how much money consumers would have to repay if they receive too large a subsidy in the health insurance exchanges after 2014.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
An inexpensive test and single-dose treatment could help save the lives of nearly one million infants annually if pregnant women in low-income countries were offered rapid tests for syphilis, experts from the Global Congenital Syphilis Partnership said on Thursday, Reuters reports.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 92.4 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 97.7 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 80.6 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 4.5 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.1 | 96.4 |
News Archive
Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.
Senate leaders announced a deal late Tuesday to stave off deep cuts to physicians' Medicare payments by repurposing money set aside for the health law, Politico reports. The deal, announced by Senate Majority Leader Harry Reid, D-Nev., and Minority Leader Mitch McConnell, R-Ky., changes ... "how much money consumers would have to repay if they receive too large a subsidy in the health insurance exchanges after 2014.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
An inexpensive test and single-dose treatment could help save the lives of nearly one million infants annually if pregnant women in low-income countries were offered rapid tests for syphilis, experts from the Global Congenital Syphilis Partnership said on Thursday, Reuters reports.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 90.5 | 79.6 |
How often patients got better at getting in and out of bed | 79 | 81.1 |
How often patients got better at bathing | 65.1 | 82.3 |
How often patients’ breathing improved | 24.6 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 47.9 | 75 |
How often home health patients had to be admitted to the hospital | 7.6 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 7.6 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 95.5 | 94 |
News Archive
Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.
Senate leaders announced a deal late Tuesday to stave off deep cuts to physicians' Medicare payments by repurposing money set aside for the health law, Politico reports. The deal, announced by Senate Majority Leader Harry Reid, D-Nev., and Minority Leader Mitch McConnell, R-Ky., changes ... "how much money consumers would have to repay if they receive too large a subsidy in the health insurance exchanges after 2014.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
An inexpensive test and single-dose treatment could help save the lives of nearly one million infants annually if pregnant women in low-income countries were offered rapid tests for syphilis, experts from the Global Congenital Syphilis Partnership said on Thursday, Reuters reports.
› Verified 7 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | Not Available |
Health team communicated well with them | Not Available |
Health team discussed medicines, pain, and home safety | Not Available |
How patients rated overall care from agency | Not Available |
News Archive
Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.
Senate leaders announced a deal late Tuesday to stave off deep cuts to physicians' Medicare payments by repurposing money set aside for the health law, Politico reports. The deal, announced by Senate Majority Leader Harry Reid, D-Nev., and Minority Leader Mitch McConnell, R-Ky., changes ... "how much money consumers would have to repay if they receive too large a subsidy in the health insurance exchanges after 2014.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
An inexpensive test and single-dose treatment could help save the lives of nearly one million infants annually if pregnant women in low-income countries were offered rapid tests for syphilis, experts from the Global Congenital Syphilis Partnership said on Thursday, Reuters reports.
› Verified 7 days ago
The patient survey data of Guardian Angel Home Health Inc is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 99 | 88 |
Percent of patients who reported that their home health team communicated well with them | 90 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 100 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 98 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 91 | 78 |
News Archive
Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.
Senate leaders announced a deal late Tuesday to stave off deep cuts to physicians' Medicare payments by repurposing money set aside for the health law, Politico reports. The deal, announced by Senate Majority Leader Harry Reid, D-Nev., and Minority Leader Mitch McConnell, R-Ky., changes ... "how much money consumers would have to repay if they receive too large a subsidy in the health insurance exchanges after 2014.
Acorda Therapeutics, Inc. today announced that AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg is now available by prescription in the United States and Puerto Rico. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.
An inexpensive test and single-dose treatment could help save the lives of nearly one million infants annually if pregnant women in low-income countries were offered rapid tests for syphilis, experts from the Global Congenital Syphilis Partnership said on Thursday, Reuters reports.
› Verified 7 days ago
Med-life Home Health, Inc Location: 1701 W Burbank Blvd, Suite 203, Burbank, California 91506 Ratings: Phone: (818) 569-0209 | |
Revive Home Health Care, Inc Location: 1918 W Magnolia Blvd, Suite 200, Burbank, California 91506 Ratings: Phone: (909) 949-6566 | |
Zion Nursing Services, Inc Location: 224 East Olive Ave, Suite 214, Burbank, California 91502 Ratings: Phone: (818) 736-5358 | |
Lakewood Home Health & Palliative Care Inc Location: 539 N Glenoaks Blvd, Suite 301f, Burbank, California 91502 Ratings: Phone: (626) 414-3358 | |
Oc Home Health Care, Inc Location: 2001 W Magnolia Blvd, Burbank, California 91502 Ratings: Phone: (747) 229-9200 | |
Allstar Home Healthcare, Inc Location: 2001 West Magnolia Blvd, Suite A1, Burbank, California 91506 Ratings: Phone: (818) 556-5270 |